-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14

Benzinga·10/12/2026 10:21:02
BTIG analyst Jeet Mukherjee initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $14.